BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6107664)

  • 41. Response of alkaline phosphatase to zinc repletion in hypozincemic hemodialysis patients.
    Stammler G; Klooker P; Bommer J; Ziegler T; Fiehn W; Manthey J; Ritz E
    Blood Purif; 1985; 3(4):192-8. PubMed ID: 3914306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The importance of dietary protein in the zinc deficiency of uremia.
    Blendis LM; Ampil M; Wilson DR; Kiwan J; Labranche J; Johnson M; Williams C
    Am J Clin Nutr; 1981 Dec; 34(12):2658-61. PubMed ID: 7315767
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapy Insight: sexual dysfunction in patients with chronic kidney disease.
    Finkelstein FO; Shirani S; Wuerth D; Finkelstein SH
    Nat Clin Pract Nephrol; 2007 Apr; 3(4):200-7. PubMed ID: 17389889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Taste acuity and zinc in uremic patients undergoing long-term hemodialysis.
    Chen HJ; Lai YH; Lin SM; Tsai JH
    Taiwan Yi Xue Hui Za Zhi; 1987 Feb; 86(2):158-63. PubMed ID: 3471859
    [No Abstract]   [Full Text] [Related]  

  • 45. [The comparative characteristics of parlodel, zinc sulfate and recombinant erythropoietin in treating uremic hypogonadism in patients on chronic hemodialysis].
    Kukhtevich AV; Ermolenko VM; Dedov II; Gitel' EP; Buniatian AF; Smirnova GA
    Ter Arkh; 1992; 64(11):66-70. PubMed ID: 1293848
    [No Abstract]   [Full Text] [Related]  

  • 46. Analysis of sexual functions in male nondiabetic hemodialysis patients and renal transplant recipients.
    Al Khallaf HH
    Transpl Int; 2010 Feb; 23(2):176-81. PubMed ID: 19778342
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [L-dopa in sexual impotence in the diabetic].
    Serrano PA; Lona R; Domínguez de la Piedra O; Carrasco-Zanini J; Carrillo AA; Zaldivar HM
    Prensa Med Mex; 1972; 37(5):163-6. PubMed ID: 4560683
    [No Abstract]   [Full Text] [Related]  

  • 48. Sexual dysfunction in patients under dialytic treatment.
    Dachille G; Pagliarulo V; Ludovico GM; Ralph D; Pagliarulo A
    Minerva Urol Nefrol; 2006 Jun; 58(2):195-200. PubMed ID: 16767073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical efficacy of sildenafil in patients on chronic dialysis.
    Chen J; Mabjeesh NJ; Greenstein A; Nadu A; Matzkin H
    J Urol; 2001 Mar; 165(3):819-21. PubMed ID: 11176477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of zinc treatment on serum thyroid hormones in uremic patients under peritoneal dialysis.
    Arreola F; Paniagua R; Pérez A; Díaz-Bensussen S; Junco E; Villalpando S; Exaire E
    Horm Metab Res; 1993 Oct; 25(10):539-42. PubMed ID: 8262464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical trial of mustong on secondary sexual impotence in male married diabetics.
    Ojha JK; Roy CK; Bajpai HS
    J Med Assoc Thai; 1987 Mar; 70 Suppl 2():228-30. PubMed ID: 3298520
    [No Abstract]   [Full Text] [Related]  

  • 52. Impotence in patients with uremia: a possible role for parathyroid hormone.
    Massry SG; Goldstein DA; Procci WR; Kletzky OA
    Nephron; 1977; 19(6):305-10. PubMed ID: 927622
    [No Abstract]   [Full Text] [Related]  

  • 53. Tissue potassium in chronic dialysis patients.
    Butkus DE; Alfrey AC; Miller NL
    Nephron; 1974; 13(4):314-24. PubMed ID: 4609294
    [No Abstract]   [Full Text] [Related]  

  • 54. [Erectile dysfunctions in patients treated with hemodialysis and kidney transplantation].
    Breza J; Reznícek J; Pribylincová V; Zvara P
    Bratisl Lek Listy; 1993 Sep; 94(9):489-93. PubMed ID: 8004499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sildenafil for diabetic men with erectile dysfunction.
    Karlawish JH; Casarett D
    JAMA; 1999 Sep; 282(10):940-1. PubMed ID: 10485673
    [No Abstract]   [Full Text] [Related]  

  • 56. [Sildenafil in erectile dysfunction].
    Dreifuss P
    Praxis (Bern 1994); 2002 Mar; 91(13):563-5. PubMed ID: 11998203
    [No Abstract]   [Full Text] [Related]  

  • 57. [Sexuality changes in a hemodialysis patient with hyperprolactinemia: therapeutic possibilities].
    Mondaini F; Gavazzi M; Benelli R; De Maio P
    Riv Ital Ginecol; 1980; 59 Suppl():93-6. PubMed ID: 6813937
    [No Abstract]   [Full Text] [Related]  

  • 58. Phosphodiesterase type 5 inhibitor treatment for erectile dysfunction in patients with end-stage renal disease receiving dialysis or after renal transplantation.
    Lasaponara F; Sedigh O; Pasquale G; Bosio A; Rolle L; Ceruti C; Timpano M; Negro CL; Paradiso M; Abbona A; Segoloni GP; Fontana D
    J Sex Med; 2013 Nov; 10(11):2798-814. PubMed ID: 23346948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapy of erectile dysfunction. Sildenafil remains the gold standard].
    MMW Fortschr Med; 2001 Dec; 143(49-50):50-1. PubMed ID: 11808451
    [No Abstract]   [Full Text] [Related]  

  • 60. [Sexual function and quality of life in hemodialysis male patients].
    Martín-Díaz F; Reig-Ferrer A; Ferrer-Cascales R
    Nefrologia; 2006; 26(4):452-60. PubMed ID: 17058857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.